Understanding the Runner's High: Exercise and the Endocannabinoid System

If you've ever experienced that moment during exercise when fatigue suddenly transforms into euphoria, you've encountered what researchers call the "runner's high." For decades, this phenomenon has been attributed to endorphins—the body's natural opioids. However, emerging research reveals a different story, one that has significant implications for both exercise science and therapeutic cannabis applications.

The Traditional Endorphin Theory

The endorphin explanation for runner's high emerged in the 1980s when researchers observed elevated β-endorphin levels in blood following exercise. This finding seemed to provide a clear mechanism: exercise triggers stress, the body releases endorphins to manage discomfort, and the result is euphoria.

While intuitive, Dr. Arne Dietrich, a neuroscientist who has spent years studying the runner’s high, says this theory of mechanism has a fundamental flaw. "Peripheral endorphins do not have a major effect on the brain because they cannot cross the blood-brain barrier due to their hydrophilic structure." In simple terms, endorphins are too water-loving (hydrophilic) to pass through the protective barrier that separates the bloodstream from the brain. This means the endorphins circulating in your bloodstream after exercise cannot reach the brain regions responsible for mood and perception.

More compelling evidence against the endorphin theory comes from studies using naltrexone, a medication that blocks opioid receptors. When researchers gave participants naltrexone before exercise, the runner's high persisted unchanged, suggesting that endorphins are not the primary mechanism behind exercise-induced euphoria.

Enter the Endocannabinoid System and the Body’s Natural Cannabis

The real explanation for runner's high lies in the endocannabinoid system, a biological system that most people have never heard of, even though it's one of the most important regulatory networks in the human body.

Just as the body makes its own endorphins (endo = internal), it also produces its own cannabinoid-like compounds called endocannabinoids, including anandamide (from the Sanskrit word for bliss or joy) and 2-arachidonylglycerol (2-AG). These molecules are remarkably similar to the compounds found in cannabis plants, and unlike endorphins are lipophilic (fat-soluble), allowing them to cross the blood-brain barrier easily and directly influence mood, pain perception, and stress response through cannabinoid receptors CB1 and CB2.

The Research Evidence

Animal Studies

In 2015, researchers demonstrated that the anxiolytic (anxiety-reducing) and analgesic (pain-relieving) effects of exercise in mice depend entirely on cannabinoid receptors, not opioid receptors. When researchers blocked the endocannabinoid system, exercise-induced benefits disappeared. Blocking the opioid system had no effect on the runner's high. However, mice aren’t humans, so researchers need to test this on people.

Human Studies

A 2021 study examined 63 participants who ran for 45 minutes at moderate intensity or walked leisurely. Half received naltrexone to block endorphin activity. The people who had their endorphin systems blocked experienced the same benefits (a sense of euphoria and reduced anxiety) as those who didn't. The runner's high occurred without endorphins and was correlated with higher levels of endocannabinoids. The walkers also showed an increase in endocannabinoid levels, but to a lesser degree than the runners.

Systematic Review

A 2022 systematic review analyzing studies from 1992 to 2021 found that 14 of 17 qualifying studies demonstrated exercise-induced increases in endocannabinoid levels, establishing a consistent pattern across research populations.

 

Clinical Implications

Exercise Prescription Parameters

Research indicates that moderate-intensity exercise (~60–85% of maximum heart rate) sustained for 20-30 minutes optimally stimulates endocannabinoid production. This "therapeutic window" provides guidance for healthcare providers developing exercise protocols for patients with anxiety, chronic pain, or mood disorders.

Integration with Cannabis Therapy

For healthcare professionals, especially those working with patients using medical cannabis, this research offers intriguing possibilities. The endocannabinoid system activated by exercise is the same system targeted by therapeutic cannabis. Exercise naturally increases your body's production of endocannabinoids, while medical cannabis supplies external cannabinoids that act on the same receptors.

Understanding that exercise activates the same system targeted by medical cannabis offers a scientific basis for explaining why movement feels so good and can be therapeutic for conditions ranging from chronic pain to PTSD.

Although more research is necessary, for patients dealing with anxiety, chronic pain, depression, or inflammatory conditions, combining appropriate exercise with cannabis therapy may offer synergistic benefits. However, further research is still needed.

Individual Variability

Just as people respond differently to cannabis medications, endocannabinoid responses to exercise vary significantly between individuals. Some people may experience robust effects from moderate exercise, while others may require different intensities or durations to achieve therapeutic benefits.

The Chronic Exercise Paradox

An interesting paradox arises with long-term training: while acute exercise consistently raises endocannabinoid levels, studies show that after prolonged periods of regular training, baseline endocannabinoid levels actually decline.

This may explain why experienced runners sometimes need to push harder or run longer to get the same euphoric feelings they used to experience more easily. It's not that the system stops functioning; it's more efficient and might need different stimuli to trigger it.

This adaptation pattern mirrors that of many biological systems: initial sensitivity followed by accommodation and the need for variation to maintain response.

Broader Therapeutic Applications

The endocannabinoid system's role in exercise effects extends beyond feeling good during workouts. It plays an important role in:

Pain Management: Exercise-induced analgesia operates through endocannabinoid pathways, offering non-pharmaceutical approaches to pain relief that healthcare providers can confidently recommend.

Stress, Anxiety, Mood: Exercise's anxiolytic effects operate through the same cannabinoid receptors that control stress response, offering evidence-based support for exercise therapy to improve mood and emotional regulation.

Sleep Regulation: Endocannabinoids help modulate sleep-wake cycles, which may explain why regular exercisers often sleep well.

Inflammation Control: The endocannabinoid system helps regulate inflammatory responses, contributing to exercise's anti-inflammatory effects.

Future Directions

As our understanding of individual endocannabinoid responses develops, we may see more personalized approaches to exercise therapy. Just as we're beginning to understand individual differences in cannabis response, we may develop ways to predict and optimize individual endocannabinoid responses to exercise.

Potential developments include:

• Biomarker-guided exercise prescriptions

• Genetic testing to optimize individual exercise protocols

• Combination therapies integrating exercise with targeted endocannabinoid interventions

• Better prediction of which patients will respond optimally to exercise therapy

Bottom Line

When you go for a run, bike ride, or do any moderate exercise, you're not just burning calories or building strength—you're activating your endocannabinoid system, the same biological network that cannabis targets. That runner's high you feel isn't about endorphins; it's your body releasing its own cannabis-like compounds that bind to cannabinoid receptors, producing euphoria, easing anxiety, and providing natural pain relief.

This discovery fundamentally changes how we understand the connection between movement and well-being. For healthcare professionals, it provides a strong, evidence-based rationale for exercise therapy. The clinical implications extend far beyond feeling good during workouts—exercise-induced endocannabinoid activation offers non-pharmaceutical approaches to pain management, anxiety reduction, sleep improvement, and inflammation control. This gives providers scientifically grounded confidence when recommending exercise for conditions ranging from chronic pain to PTSD.

For patients, this research validates what many instinctively know: consistent, moderate exercise can be profoundly therapeutic. The euphoria you experience isn't just psychological; it's your endocannabinoid system functioning exactly as designed. Whether you're managing chronic pain, anxiety, or seeking better overall wellness, understanding this connection empowers you to use exercise as medicine.

The ancient wisdom of "a sound mind in a sound body" now has modern scientific backing. Your body contains its own internal pharmacy, complete with natural cannabis-like compounds waiting to be activated through movement.

So the next time someone talks about chasing their endorphin high, you can share the real story: you're not chasing endorphins—you're tapping into your endocannabinoid system, activating your body's own "bliss" compounds.

________________________________________________________________________________________

This information is for educational purposes only and should not replace professional medical advice. Healthcare providers should consult current literature when developing treatment recommendations, and patients should discuss exercise programs with their healthcare team. Individuals should consult with healthcare providers before beginning new exercise programs or making changes to their wellness routines.

References

Desai, S., Borg, B., Cuttler, C., Fadus, M. C., & Kelley, A. M. (2022). A systematic review and meta-analysis on the effects of exercise on the endocannabinoid system. Cannabis and Cannabinoid Research, 7(4), 388–408. 

Dietrich, A., & McDaniel, W. F. (2004). Endocannabinoids and exercise. British Journal of Sports Medicine, 38(5), 536–541.

Fuss, J., Steinle, J., Bindila, L., Auer, M. K., Kirchherr, H., Lutz, B., & Gass, P. (2015). A runner's high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences, 112(42), 13105–13108. 

Hillard, C. J. (2017). Circulating endocannabinoids: From whence do they come and where are they going? Neuropsychopharmacology, 42(1), 155–172. 

Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A., & Gerdeman, G. L. (2013). Exercise-induced endocannabinoid signaling is modulated by intensity. European Journal of Applied Physiology, 113(4), 869–875. 

Siebers, M., Biedermann, S. V., & Fuss, J. (2023). Do endocannabinoids cause the runner's high? Evidence and open questions. Neuropsychopharmacology, 48(3), 352–369. 

Siebers, M., Biedermann, S. V., Bindila, L., Lutz, B., & Fuss, J. (2021). Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans. Psychoneuroendocrinology, 126, 105173. 

Sparling, P. B., Giuffrida, A., Piomelli, D., Rosskopf, L., & Dietrich, A. (2003). Exercise activates the endocannabinoid system. NeuroReport, 14(17), 2209–2211.